RIC Annual Meeting Program

8:30 - 5:30pm Registration  
9:00 - 9:15am Welcome & Opening Remarks Kevin Holman, MBA RAC

Janssen Pharmaceutical Companies of Johnson & Johnson

Chairman of the RIC Board of Directors
9:15 - 10:30am Opening Panel: Why RIC, Why NOW?

Linda Pissott Reig, Moderator

Buchanan, Ingersoll & Rooney PC

Kevin Holman

Janssen Pharmaceutical Companies

of Johnson & Johnson

Michael Cheung

Bristol-Myers Squibb

Jennifer Church

Viatris

Kal Elhoregy, RPh, PA

Amneal Pharmaceuticals, Inc.

Kishore Gopu

Teva Pharmaceutical Industries Ltd.

Sherice Mills

Jazz Pharmaceuticals

10:30 - 11:00am Coffee Break & Networking  
11:00 - 12:00pm Stakeholder Feedback on REMS Functionality and Operability

Jason Ancell

Gilead Sciences

Sherice Mills

Jazz Pharmaceuticals

12:00 - 1:00pm Lunch & Networking  
1:00 - 2:00pm REMS Data Standardization: Codex

Challenges & Opportunities
Kelee Petzelt

Point-of-Care Partners

Edward Millikan, PharmD

FDA (invited)
2:00 - 2:45pm REMS-Related Regulatory & Legislative Update Brianna Gallagher, Moderator

Viatris
2:45 - 3:15pm Break  
3:15 - 4:15 pm Is Your REMS Ready for Release?

Jason Ancell, Moderator

Gilead Sciences

4:15 - 4:30 PM Closing Remarks Kevin Holman, MBA RAC

Chairman of the RIC Board of Directors
5:00 - 6:30 PM Reception & Networking Assembly (1700 N Moore St, Arlington, VA 22209)  Right next door to Convene  

Day 2 March 23, 2023

8:30 - 9:00am Breakfast  
9:00 - 9:45am RIC Membership Business Meeting

(To include all voting and non-voting members)
 
9:45 - 10:30am The Regulator's View Elaine Lippmann, JD

FDA (Invited)
10:30 - 10:45am Coffee Break & Networking  
10:45 - 11:30am Global Safety Surveillance

Linda Pissott Reig, Moderator

Buchanan, Ingersoll & Rooney PC

Jamie Wilkins 

Pfizer

Tracy Hernandez

Bristol Meyers Squibb

11:30 - 12:15pm

Current State of REMS Initiatives

Claudia Manzo, PharmD

FDA (Invited)

Edward Millikan, PharmD

FDA (invited)

12:15 - 1:15pm Lunch & Networking  
1:15 - 2:00pm Technology: Are we asking the right questions? Kyle Irwin, Moderator

Janssen Pharmaceutical Companies

of Johnson & Johnson
2:00 - 2:30pm Wrap-Up & Call to Future Action Kevin Holman, MBA RAC

Chairman of the RIC Board of Directors